Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
Expert Review of Hematology|March 10, 2018
Novel tyrosine-kinase inhibitors for the treatment of chronic myeloid leukemia: safety and efficacyFulvio Massaro, Gioia Colafigli, Matteo Molica, et al.Leukemia Research|July 22, 2016
Early molecular response in chronic myeloid leukemia and halving time: Latest evidencesMassimo Breccia, Matteo Molica, Gioia Colafigli, et al.Cancers|February 25, 2022
Brentuximab Vedotin and Pembrolizumab Combination in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Single-Centre Retrospective AnalysisFulvio Massaro, Nathalie Meuleman, Dominique Bron, et al.World Journal of Clinical Cases|September 28, 2019
Atypical cutaneous lesions in advanced-stage Hodgkin lymphoma: A case reportFulvio Massaro, Angela Ferrari, Enrico Zendri, et al.Cancers|January 1, 2021
Aging of Bone Marrow Mesenchymal Stromal Cells: Hematopoiesis Disturbances and Potential Role in the Development of Hematologic CancersFulvio Massaro, Florent Corrillon, Basile Stamatopoulos, et al.International Journal of Molecular Sciences|April 12, 2022
New Perspectives in Treating Acute Myeloid Leukemia: Driving towards a Patient-Tailored StrategyFabio Andreozzi, Fulvio Massaro, Sebastian Wittnebel, et al.Biomedicines|May 25, 2024
Beyond Chemotherapy: Present and Future Perspectives in the Treatment of Lymphoproliferative DisordersFulvio Massaro, Fabio Andreozzi, Tom Abrassart, et al.Seminars in Thrombosis and Hemostasis|June 3, 2016
Severe Thrombotic Complications in Congenital Afibrinogenemia: A Pathophysiological and Management DilemmaCristina Santoro, Fulvio Massaro, Salvatore Venosi, et al.Frontiers in Immunology|December 22, 2023
Age-related changes in human bone marrow mesenchymal stromal cells: morphology, gene expression profile, immunomodulatory activity and miRNA expressionFulvio Massaro, Florent Corrillon, Basile Stamatopoulos, et al.Annals of Hematology|May 29, 2018
Changes in estimated glomerular filtration rate in chronic myeloid leukemia patients treated front line with available TKIs and correlation with cardiovascular eventsMatteo Molica, Emilia Scalzulli, Gioia Colafigli, et al.Pageof 4